Aspira Pathlab & Diagnostics Ltd. (ASPIRA): Aspira Pathlab & Diagnostics Share Price rises 4.98% near 52-week high
- September 28, 2026
- Posted by: Chaitanya Auti
- Category: News
Aspira Pathlab & Diagnostics Share Price is trading at Rs 136.5, up 4.98% today, and remains close to its 52-week high while the company’s market capitalisation stands at Rs 133.83 crore.
Aspira Pathlab & Diagnostics Share Price is in focus after the stock traded at Rs 136.5 on 28 September 2026 at 1:22 PM IST, up Rs 6.48 from the previous close of Rs 130.02. The move has kept Aspira Pathlab & Diagnostics Share Price close to its 52-week high and has placed the name in current market watchlists, while its market capitalisation remains Rs 133.83 crore. The latest Univest data confirms the price event, but it does not establish any company-specific catalyst. For readers tracking Aspira Pathlab & Diagnostics Share Price Today, the key takeaway is that the stock is holding near a yearly high after an intraday move that took it to Rs 136.5.
Aspira Pathlab & Diagnostics Share Price Today: Price Action Analysis
The latest Aspira Pathlab & Diagnostics Share Price update also shows that the stock opened at Rs 136 and touched a day high of Rs 136.5, while the day low was Rs 124.01. That range gives a clear picture of the day’s price action without adding any unsupported explanation. Aspira Pathlab & Diagnostics Stock News therefore centres on the observed move itself, along with valuation and healthcare-sector context discussed later in this article.
| Metric | Value |
|---|---|
| Current Price | Rs 136.5 |
| Previous Close | Rs 130.02 |
| Today's Move | +Rs 6.48 (+4.98%) |
| Open | Rs 136 |
| High | Rs 136.5 |
| Low | Rs 124.01 |
| Market Capitalisation | Rs 133.83 crore |
Aspira Pathlab & Diagnostics Ltd. (ASPIRA) traded at Rs 136.5 versus the previous close of Rs 130.02, a rise of 4.98%. The stock opened at Rs 136, reached a high of Rs 136.5 and touched a low of Rs 124.01.
Aspira Pathlab & Diagnostics Share Price Today shows a day move of Rs 6.48, or 4.98%, against the previous close of Rs 130.02. The stock is trading at Rs 136.5, the same as the day high, after opening at Rs 136 and marking a low of Rs 124.01. That places Aspira Pathlab & Diagnostics Share Price close to its 52-week high and within a narrow band near the upper end of the day’s range. For readers following Aspira Pathlab & Diagnostics Share Price Live, the latest print confirms that the near-yearly-high event is being reflected directly in the price.
Aspira Pathlab & Diagnostics Share Price News remains relevant because the stock is holding above the previous close by a visible margin, while the market capitalisation is still Rs 133.83 crore. The move is a factual price event and not a stated catalyst story. The current setup makes Aspira Pathlab & Diagnostics Share Price a stock worth tracking alongside the broader stock market today and share market today screen for 52 week high stocks.
Aspira Pathlab & Diagnostics Ltd. (ASPIRA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 133.83 crore |
| P/E Ratio | 55.79x |
| P/B Ratio | 10.59x |
| ROE | 18.13% |
| ROCE | 19.27% |
| EPS | Rs 2.33 |
| Book Value Per Share | Rs 12.28 |
| Dividend Yield | 0% |
Aspira Pathlab & Diagnostics Ltd. (ASPIRA) fundamental metrics show P/E 55.79x, P/B 10.59x, ROE 18.13%, ROCE 19.27%. These figures provide context only and are not a buy or sell signal.
Aspira Pathlab & Diagnostics Ltd. has a market capitalisation of Rs 133.83 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 55.79x, P/B at 10.59x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.13% and ROCE of 19.27%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 2.33, book value per share of Rs 12.28, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 44.07x, median ROE of 12.77%, median ROCE of 15.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 55.79x |
| Benchmark Median P/E | 44.07x |
| Benchmark Average P/E | 90.35x |
| Benchmark P/E Range | 0x to 1,602.7x |
| Company P/B Ratio | 10.59x |
| Benchmark Median P/B | 3.22x |
| Company ROE | 18.13% |
| Benchmark Median ROE | 12.77% |
| Company ROCE | 19.27% |
| Benchmark Median ROCE | 15.61% |
| Company Market Capitalisation | Rs 133.83 crore |
| Benchmark Median Market Cap | Rs 544.65 crore |
Aspira Pathlab & Diagnostics Ltd. (ASPIRA) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
Aspira Pathlab & Diagnostics Ltd. (ASPIRA) has a P/E ratio of 55.79x, which is above the benchmark median of 44.07x, a difference of +26.59%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Aspira Pathlab & Diagnostics Ltd. (ASPIRA) has a ROE of 18.13%, which is above the benchmark median of 12.77%, a difference of +41.97%. Aspira Pathlab & Diagnostics Ltd. (ASPIRA) has a ROCE of 19.27%, which is above the benchmark median of 15.61%, a difference of +23.45%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Star Imaging and Path Lab Ltd. | STARIMAGIN | 135.35 | 7.02 | 1.17 | 40.65 | 33.81 |
| Nephro Care India Ltd. | NEPHROCARE | 154.23 | 45.78 | 2.64 | 10.62 | 14.42 |
| MODERN DIAGNOSTIC & RESEARCH C | MDRC | 114.38 | 21.77 | 1.99 | 55.21 | 39 |
| Vaidya Sane Ayurved Laboratories Ltd. | MADHAVBAUG | 169.53 | 18.86 | 2.71 | 13.66 | 16.7 |
| Invicta Diagnostic Ltd. | INVICTA | 88 | 17.94 | 1.71 | 40.48 | 42.85 |
Aspira Pathlab & Diagnostics Ltd. (ASPIRA) has a P/E ratio of 55.79x compared with the displayed peer median of 18.86x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.13% compares with a peer median of 40.48% across the companies shown in the table. ROCE stood at 19.27% versus the displayed peer median of 33.81%, providing a capital-efficiency comparison. Aspira Pathlab & Diagnostics Ltd. (ASPIRA) has a market capitalisation of Rs 133.83 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Aspira Pathlab & Diagnostics
- Aspira Pathlab & Diagnostics Share Price is trading at Rs 136.5, up 4.98% from the previous close.
- The stock is near its 52-week high and one-year high on the latest trade.
- P/E is 55.79 and P/B is 10.59, both above the same-industry medians.
- ROE is 18.13% and ROCE is 19.27%, both above the benchmark medians.
- Market capitalisation stands at Rs 133.83 crore, which helps place Aspira Pathlab & Diagnostics Share Price in context within the healthcare universe.
About Aspira Pathlab & Diagnostics
Aspira Pathlab & Diagnostics Share Price belongs to Aspira Pathlab & Diagnostics Ltd., which operates in the Healthcare sector and the Hospital & Healthcare Services industry. The company’s market data places it within a broad listed peer group that includes diagnostics and hospital-focused names. Aspira Pathlab & Diagnostics Stock News is therefore read through both company-specific metrics and the wider healthcare benchmark set. For readers tracking Aspira Pathlab & Diagnostics Share Price Today, this company profile provides the sector and industry context used in valuation comparisons.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Aspira Pathlab & Diagnostics Share Price in focus today?
Ans. Aspira Pathlab & Diagnostics Share Price is in focus because it is trading at Rs 136.5, up 4.98% from the previous close, and remains close to its 52-week high during the current market session.
What is the current Aspira Pathlab & Diagnostics Share Price?
Ans. Aspira Pathlab & Diagnostics Share Price is Rs 136.5 as of 28 September 2026 at 1:22 PM IST. The stock is above the previous close of Rs 130.02 and is trading near its yearly high.
How much did Aspira Pathlab & Diagnostics Share Price move today?
Ans. Aspira Pathlab & Diagnostics Share Price moved up by Rs 6.48, or 4.98%, compared with the previous close. The day high is Rs 136.5 and the day low is Rs 124.01, showing the day’s range.
Is Aspira Pathlab & Diagnostics Share Price near a 52-week high?
Ans. Yes, Aspira Pathlab & Diagnostics Share Price is trading near its 52-week high. The latest trade at Rs 136.5 places the stock close to its yearly peak on the current market reading.
What is the market capitalisation of Aspira Pathlab & Diagnostics?
Ans. Aspira Pathlab & Diagnostics has a market capitalisation of Rs 133.83 crore. That figure helps position Aspira Pathlab & Diagnostics Share Price within the healthcare listed-company universe and benchmark comparisons.
How do the valuation metrics look for Aspira Pathlab & Diagnostics Share Price?
Ans. Aspira Pathlab & Diagnostics Share Price is associated with a P/E ratio of 55.79 and a P/B ratio of 10.59. Both are above the same-industry medians shown in the healthcare benchmark set.
What do ROE and ROCE say about Aspira Pathlab & Diagnostics?
Ans. ROE is 18.13% and ROCE is 19.27% for Aspira Pathlab & Diagnostics. Both sit above the same-industry medians, which gives Aspira Pathlab & Diagnostics Share Price additional financial context.
How does Aspira Pathlab & Diagnostics compare with peers?
Ans. In peer comparison, Aspira Pathlab & Diagnostics Share Price has a higher P/E than several listed peers, while ROE and ROCE sit above some peers and below others. The comparison is mixed and should be read with valuation context.
Track Aspira Pathlab & Diagnostics Share Price on Univest
Use Aspira Pathlab & Diagnostics Ltd. (ASPIRA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.